PharmiWeb8m
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...
PharmiWeb10m
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
PharmiWeb2h
Global Bone Screw System Market Projected to Reach…
The global bone screw system market is poised for robust and steady growth over the next decade, with new projections indicating the market could nearly double in value by 2034. Currently valued at ...
PharmiWeb2h
Global Drug Designing Tools Market to Surge with 8.7% CAGR, Projected to Reach USD 7.1 Billion by 2033
The global drug designing tools market is poised for significant expansion, anticipated to grow at a steady Compound Annual Growth Rate (CAGR) of 8.7% from 2023 to 2033. According to industry experts, ...
PharmiWeb2h
Global Orthopedic Prosthetics Market Poised for Significant Growth, Projected to Reach USD 3,908.2 Million by 2034
The global orthopedic prosthetics market is set for substantial expansion, with sales projected to soar from USD 2,399.3 million in 2024 to a remarkable USD 3,908.2 million by 2034. This growth ...
PharmiWeb2h
Global Dialysis Equipment Market Set for Remarkable Growth, Projected to Reach USD 17,780.9 Million by 2034 at a CAGR of 4.8%
The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...
PharmiWeb2h
Global Bioprocessing Analytics Equipment Market Poised for Significant Growth, Forecasted to Reach USD 633.6 Million by 2028
The global bioprocessing analytics equipment market is on the threshold of transformative growth, with recent projections anticipating a revenue increase from USD 485.1 million in 2022 to USD 633.6 ...
PharmiWeb2h
Global Neurological Biomarkers Market Poised for Strong Growth, Projected to Reach USD 12.5 Billion by 2033
The global neurological biomarkers market is set to experience significant expansion in the coming years, driven by a growing demand for accurate diagnostic tools and advanced treatment monitoring ...
PharmiWeb3h
Global Vulvodynia Treatment Market to Reach USD 12…
The global vulvodynia treatment market is poised for significant growth, with sales expected to rise from USD 6.7 billion in 2025 to USD 12.4 billion by 2035, reflecting a CAGR of 6.3% over the ...
PharmiWeb3h
Global Nucleic Acid Testing Market Poised to Reach USD 7.2 Billion by 2033 Amid Rising Demand for Advanced Diagnostics | FMI
The global nucleic acid testing market is witnessing unprecedented growth, with a market size of USD 3.7 billion in 2023, driven by a robust compound annual growth rate (CAGR) of 6.8%. By the end of ...
PharmiWeb4h
Lotus Pharmaceutical becomes strategic partner for…
AgreementLotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region 05.02.2025 / 06:30 CET/CESTThe issuer is ...
PharmiWeb11h
Adolore BioTherapeutics to Present CA8* Neuromodulating Gene Therapy at the 2025 NANS Annual Meeting
DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...